Arcturus Therapeutics Holdings Inc. (ARCT) vs REGENXBIO Inc. (RGNX)
A side-by-side comparison of Arcturus Therapeutics Holdings Inc. and REGENXBIO Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARCT
Arcturus Therapeutics Holdings Inc.
$13.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
RGNX
REGENXBIO Inc.
$7.45HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ARCT vs RGNX
growth of $100 · dividends reinvested · last 10yARCT -18.2% (-2.0%/yr)RGNX -52.1% (-7.1%/yr)ARCT compounded faster over this window
ARCT RGNX
ARCT vs RGNX: by the numbers
- •RGNX is the larger company ($385M vs $369M market cap).
- •Both run net losses; RGNX's is the smaller (-112.58% vs -391.90% net margin).
- •ARCT grew revenue faster over the past five years (22.30% vs 1.59% CAGR).
Metrics side by side
Valuation
| Metric | ARCT | RGNX |
|---|---|---|
| P/S ratio | 15.52 | 2.21 |
| P/B ratio | 2.15 | 5.37 |
Profitability
| Metric | ARCT | RGNX |
|---|---|---|
| Gross margin | 95.50% | 88.09% |
| Operating margin | -111.51% | -94.08% |
| Net margin | -391.90% | -112.58% |
| ROE | -54.29% | -273.72% |
| ROIC | -54.07% | -54.00% |
Growth (annualized)
| Metric | ARCT | RGNX |
|---|---|---|
| Revenue CAGR (5Y) | 22.30% | 1.59% |
| Total return CAGR (5Y) | -18.73% | -24.15% |
Frequently asked
- Which has grown faster, ARCT or RGNX?
- Over the past five years, ARCT grew revenue faster — ARCT at a 22.30% CAGR versus RGNX at 1.59%.
- How have ARCT and RGNX total returns compared?
- Over the past 10 years, ARCT delivered -2.54% and RGNX delivered -6.47% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Arcturus Therapeutics ROEREGENXBIO ROEArcturus Therapeutics operating marginREGENXBIO operating marginArcturus Therapeutics revenue growthREGENXBIO revenue growthArcturus Therapeutics free cash flowREGENXBIO free cash flow
Arcturus Therapeutics & REGENXBIO appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.